Advertisement
Canada markets closed

  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • DOW

    38,460.92
    -42.77 (-0.11%)
     

  • CAD/USD

    0.7298
    -0.0022 (-0.30%)
     

  • CRUDE OIL

    82.84
    +0.03 (+0.04%)
     

  • Bitcoin CAD

    88,118.52
    -2,712.11 (-2.99%)
     

  • CMC Crypto 200

    1,385.35
    -38.75 (-2.72%)
     

  • GOLD FUTURES

    2,328.90
    -13.20 (-0.56%)
     

  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • NASDAQ futures

    17,507.25
    -99.50 (-0.57%)
     

  • VOLATILITY

    15.97
    +0.28 (+1.78%)
     

  • FTSE

    8,040.38
    -4.43 (-0.06%)
     

  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     

  • CAD/EUR

    0.6819
    -0.0017 (-0.25%)
     

Syndax Pharmaceuticals, Inc. (SNDX) Shares March Higher, Can It Continue?

Zacks Equity Research
·1 min read

As of late, it has definitely been a great time to be an investor Syndax Pharmaceuticals, Inc. SNDX. The stock has moved higher by 7% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider SNDX’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as SNDX has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company. You can see the complete list of today’s Zacks #1 Rank stocks here.

7 Best Stocks for the Next 30 Days

Just released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers “Most Likely for Early Price Pops.”

ADVERTISEMENT

Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.7% per year. So be sure to give these hand-picked 7 your immediate attention.

See 7 handpicked stocks now >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Syndax Pharmaceuticals, Inc. (SNDX) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research